Citation tools
"Rationale for Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Combination Therapy with Camptothecins or Temozolomide Based on PARP Trapping versus Catalytic Inhibition." Journal of Pharmacology and Experimental Therapeutics
349.3
(2014):
408-416.
Web. 23 April. 2024.